KLRClass II
Enzyme Immunoassay, Lidocaine
21 CFR 862.3555 / Clinical Toxicology
KLR is the FDA product code for Enzyme Immunoassay, Lidocaine, a class II device type, regulated under 21 CFR 862.3555. As of , FDA records hold 17 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- KLR
- Device name
- Enzyme Immunoassay, Lidocaine
- Regulation
- 21 CFR 862.3555
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 17
- Ingested recalls
- 1
Clearances, product code KLR
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1980 | 2 |
| 1982 | 1 |
| 1983 | 7 |
| 1984 | 1 |
| 1985 | 1 |
| 1988 | 1 |
| 1997 | 1 |
| 2004 | 2 |
| 2009 | 1 |
Applicants with the most clearances
Product code KLR| Applicant | Clearances |
|---|---|
| Syva Co. | 5 |
| E.I. Dupont de Nemours & Co., Inc. | 2 |
| Abbott Medical | 1 |
| American Dade | 1 |
| American Diagnostic Corp. | 1 |
| Siemens Healthcare Diagnostics Inc. | 1 |
| Diagnostic Reagents, Inc. | 1 |
| Diagnostic Systems | 1 |
| Roche Diagnostic Systems, Inc. | 1 |
| Roche Diagnostics GmbH | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
